WHO launches Collaborating Centre on Cardiovascular Diseases, eHealth and Value-based Care in St Petersburg
The Institute of Heart and Vessels of the Almazov National Medical Research Centre, based in St Petersburg, Russian Federation, has now joined the international community of more than 800 WHO collaborating centres.
The Almazov Centre, of the Ministry of Health, is a leading national institution, which combines basic and applied research in a variety of medical fields, from cardiovascular diseases to neurosurgery. The Centre provides multidisciplinary specialized care, which includes high-tech surgery, and continuous medical education for researchers and practicing doctors.
As a WHO collaborating centre, the Institute of Heart and Vessels is now part of a multilateral international network of research, clinical and academic institutions. This community supports WHO through concrete collaboration and contributions to the implementation of its plans, projects and objectives. Specifically, the Institute will use its expertise in the areas of cardiovascular diseases, eHealth and value-based care.
A special event was held in St Petersburg on 18 October 2019 to launch the collaborating centre. Opened by Professor Evgeny Shlyakhto, Director of the Almazov Centre, alongside country and regional representatives of WHO and representatives of the Ministry of Health, the programme highlighted achievements and future plans for collaboration between WHO and the Centre to an audience representing major national and international institutions. Recent collaborative work between WHO and the Institute was shared, which included reviewing services for acute care and rehabilitation of heart attack and stroke patients in Belarus, Kyrgyzstan and Turkmenistan, as part of WHO country support.
“The potential of the Almazov Centre is extremely high,” stated Professor Shlyakhto. “With its core specializations in cardiology and angiology, it is at the forefront not only in clinical practice but also in creating the framework for the innovative development of medical science and health care towards personalized medicine. The Centre is committed to scientific and technological advancement, personnel training and rapid integration of research findings into health-care practice.” Professor Shlyakhto noted that “The Almazov Center is working on 3 megatrends: digitalization, super-specialization and personalized medicine, and can contribute its expertise to the entire Region”.
Dr Bente Mikkelsen, Director of the Division of Noncommunicable Diseases and Promoting Health through the Life-Course, WHO/Europe, added: “The Almazov Centre’s potential for impact at country level lies in its impressive broadness of activities: health policies, health education, health literacy, research and innovation, capacity-building, and digital health; an example that builds trust between institutions and people. It can help focus our efforts in the Region to reach SDG target 3.4: reducing premature mortality from noncommunicable disease”.